North America Urinalysis Market
Market Size in USD Billion
CAGR :
% 
 Forecast Period |
2024 –2031 |
 Market Size (Base Year) |
USD 1.62 Billion |
 Market Size (Forecast Year) |
USD 2.64 Billion |
 CAGR |
% |
| Major Markets Players |
|
North America Urinalysis Market, By Testing Type (Urine Biochemistry Testing and Urine Biochemistry Testing), Product (Instruments and Consumables), Test Type (Biochemical, Pregnancy and Fertility, and Sediment), Modality (Portable, Standalone, Table Top, Bench Top, and Others), Application (Disease Screening, Urinary Tract Infections, Kidney Diseases, Diabetes, Liver Diseases, Pregnancy and Fertility, and Others), End User (Hospital, Laboratory, Home Care Settings, and Others), Distribution Channel (Direct Tender and Retail Sales) – Industry Trends and Forecast to 2031.
North America Urinalysis Market Analysis and Size
A study conducted by the National Center for Biotechnology Information (NCBI) in November 2021 revealed that around 40% of women in the U.S. are at risk of developing a urinary tract infection (UTI) at some point in their lives, primarily due to the high prevalence of uncomplicated UTIs. In addition, a report released by the National Kidney Foundation in 2021 highlighted that CKD is the leading cause of death, surpassing prostate and breast cancer. Approximately 37.0 million people in the U.S., which accounts for about 15% of the adult population, are predominantly affected by CKD.
North America urinalysis market size was valued at USD 1.62 billion in 2023 and is projected to reach USD 2.64 billion by 2031, with a CAGR of 6.3% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2024 to 2031 |
|
Base Year |
2023 |
|
Historic Years |
2022 (Customizable to 2016 - 2021) |
|
Quantitative Units |
Revenue in USD Billion, Volumes in Units, Pricing in USD |
|
Segments Covered |
Testing Type (Urine Biochemistry Testing and Urine Biochemistry Testing), Product (Instruments and Consumables), Test Type (Biochemical, Pregnancy and Fertility, and Sediment), Modality (Portable, Standalone, Table Top, Bench Top, and Others), Application (Disease Screening, Urinary Tract Infections, Kidney Diseases, Diabetes, Liver Diseases, Pregnancy and Fertility, and Others), End User (Hospital, Laboratory, Home Care Settings, and Others), Distribution Channel (Direct Tender and Retail Sales) |
|
Countries Covered |
U.S., Canada, and Mexico |
|
Market Players Covered |
Siemens (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health (U.S.), Abbott (U.S.), Danaher (U.S.), Sysmex Corporation (Japan), Quidel Corporation (U.S.), BD (U.S.), Bio-Rad Laboratories, Inc. (U.S.), EKF Diagnostics (U.K.), Thermo Fisher Scientific Inc. (U.S.), ARKRAY, Inc. (Japan), ACON Laboratories, Inc. (U.S.), 77 Elektronika Kft. (Hungary), URIT Medical Electronic Group Co., Ltd. (China), Dirui Industrial Co., Ltd. (China), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), BIOBASE Group (China), ERBA Mannheim (U.K.), Alphatech Scientitfic E.I.R.L (Peru), Teco Diagnostics (U.S.), and Analyticon Biotechnologies GmbH (Germany) |
|
Market Opportunities |
|
Market Definition
Urinalysis is a diagnostic test that examines urine's physical, chemical, and microscopic properties. It is commonly used to assess the health of the urinary system and other organs, and to diagnose various medical conditions. Urinalysis can provide information about hydration levels, kidney function, urinary tract infections, and the presence of substances, such as glucose or proteins in the urine.
Urinalysis Market Dynamics
Drivers
- Rise in Chronic Kidney Disease (CKD) Cases
CKD is a serious condition characterized by gradually losing kidney function over time. The incidence of CKD increases with rise in prevalence of risk factors such as diabetes, hypertension, and obesity. Urinalysis plays a crucial role in the monitoring and managing CKD, as it can help healthcare providers assess kidney function, detect proteinuria (a common sign of kidney damage), and monitor disease progression. The rise in CKD cases globally is a significant driver for the urinalysis market.
- Rising Geriatric Population
With the increasing number of aging people, the risk of developing kidney disease increases, making regular monitoring of kidney function essential. Urinalysis is a valuable diagnostic tool for assessing kidney health and detecting early signs of kidney disease in the elderly population. The aging population is more susceptible to urinary tract issues and kidney-related diseases, leading to a higher demand for urinalysis tests for early detection and monitoring of these conditions.
Opportunities
- Technological Advancements in Urinalysis Devices
The urinalysis field is experiencing a wave of technological innovation, with new developments such as smartphone-based urinalysis apps and wearable devices. These advancements allow for convenient and efficient monitoring of urinary parameters, enabling individuals to track their health in real time. Smartphone apps can analyze urine samples using the phone's camera and provide instant results. On the other hand, wearable devices offer continuous monitoring of urinary parameters, providing valuable data for individuals and healthcare professionals. These technological innovations not only improve the accessibility of urinalysis but also open up new possibilities for remote monitoring and personalized healthcare.
- Rise in Home Healthcare
The shift towards home healthcare and self-monitoring needs convenient, user-friendly, and suitable solutions outside traditional healthcare settings. These solutions often include user-friendly testing kits allowing individuals to collect and analyze urine samples, with results available within minutes. In addition, digital platforms and telehealth services are being integrated with urinalysis devices, enabling individuals to share their results with healthcare professionals remotely. This home-based healthcare is creating more market opportunities.
Restraints/Challenges
- High Cost of Urinalysis Tests
The expenses involved in purchasing the necessary equipment and supplies, conducting the tests, and interpreting the results can be prohibitive for healthcare facilities and individuals alike. This can lead to a lower uptake of urinalysis tests, especially among low-income populations who may be unable to afford them. The cost associated with urinalysis tests can pose a significant barrier to their adoption, particularly in developing countries with limited healthcare budgets.
- Limited Access to Healthcare Services
In many developing countries, healthcare facilities are concentrated in urban areas, leaving those in rural and remote areas with limited access to diagnostic services. This lack of access can be a major barrier to adopting urinalysis tests, as individuals may have to travel long distances to reach a healthcare facility that offers them. Limited access to healthcare services, especially in rural and remote areas, can also hinder the utilization of urinalysis tests.
This urinalysis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the urinalysis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In January 2023, Siemens Healthineers acquired Acon Laboratories, a prominent supplier of urinalysis consumables. This acquisition bolstered Siemens Healthineers' position in the urinalysis market, enabling the company to enhance its product offerings and tap into new customer segments
- In September 2022, Sysmex Corp. unveiled its UF-1500 Fully Automated Urine Particle Analyzer, designed for urine sediment testing. Additionally, in 2022, the National Kidney Foundation raised over USD 600 million to support research, provide patient care, and advocate for individuals with kidney disease
- In August 2021, myLAB Box, the nation's pioneering at-home testing-to-treatment service, unveiled its latest offering: an at-home colorectal cancer screening test. This new test, which is painless and user-friendly, aims to assist physicians in detecting possible signs of colon cancer in both men and women. As with all myLAB Box test kits, samples can be easily collected at any time and from anywhere
Urinalysis Market Scope
The market is segmented on the basis of testing type, product, modality, application, end-user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Testing Type
- Urine Biochemistry Testing
- Urine Biochemistry Testing
Product
- Instruments
- Biochemical Urine Analyzers
- Automated biochemical analyzers
- Semi-automated Biochemical Analyzers
- Automated Urine Sediment Analyzers
- Microscopic Urine Analyzers
- Flow-Cytometric Urine Analyzers
- Point-Of-Care Urine Analyzers
- Consumables
- Dipsticks
- Reagents
- Disposables
- Pregnancy and Fertility Kits
Modality
- Portable
- Standalone
- Table Top
- Bench Top
- Others
Application
- Urinary Tract Infections
- Kidney Diseases
- Diabetes
- Liver Diseases
- Pregnancy and Fertility
- Others
End User
- Hospital
- Laboratory
- Home Care Settings
- Others
Distribution Channel
- Direct Tender
- Retail Sales
Urinalysis Market Regional Analysis/Insights
The market is analyzed and market size insights and trends are provided by country, testing type, product, modality, application, end-user, and distribution channel as referenced above.
The countries covered in the market are U.S., Canada, and Mexico.
The U.S. is expected to dominate the market and also be the fastest growing country due to rising numbers of urinalysis procedures and the growing adoption of urinalysis for treating liver disease and urinary tract infections. Further, the strategic initiatives pursued by major players, including the implementation of licensing agreements, are also a major driver for market growth.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The urinalysis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for urinalysis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the urinalysis market. The data is available for historic period 2011-2021.
Competitive Landscape and Urinalysis Market Share Analysis
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the market are:
- Siemens (Germany)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Cardinal Health (U.S.)
- Abbott (U.S.)
- Danaher (U.S.)
- Sysmex Corporation (Japan)
- Quidel Corporation (U.S.)
- BD (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- EKF Diagnostics (U.K.)
- Thermo Fisher Scientific Inc. (U.S.)
- ARKRAY, Inc. (Japan)
- ACON Laboratories, Inc. (U.S.)
- 77 Elektronika Kft. (Hungary)
- URIT Medical Electronic Group Co., Ltd. (China)
- Dirui Industrial Co., Ltd. (China)
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
- BIOBASE Group (China)
- ERBA Mannheim (U.K.)
- Alphatech Scientitfic E.I.R.L (Peru)
- Teco Diagnostics (U.S.)
- Analyticon Biotechnologies GmbH (Germany)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
